Vaginal Cleaning Using Povidone Iodine Before CS to Reduce Postoperative Wound Infection
NCT ID: NCT05021315
Last Updated: 2022-07-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
800 participants
INTERVENTIONAL
2021-09-15
2022-10-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Research questions:
Does vaginal cleaning using povidone iodine before cesarean section has effect on reduction of postoperative wound infection??
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preoperative Vaginal Cleansing With Povidone Iodine and the Risk of Post Cesarean Endometritis
NCT02693483
Vaginal Cleansing Before Cesarean Delivery to Reduce Infection
NCT02495753
Does Preoperative Vaginal Preparation With Povidone-iodine Before Cesarean Delivery Reduce the Risk of Endometritis?
NCT01437228
Povidone Iodine Versus Normal Saline in Preoperative Vaginal Cleansing Before Caesarean Section
NCT06950229
Povidone Iodine and Cesarean Section Wound Infections
NCT01700803
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Iodine group
50 women who received preoperative vaginal cleansing with 10% povidone-iodine.
10% povidone iodine
50 women who received preoperative vaginal cleansing with 10% povidone iodine.
Control group
50 women who did not receive preoperative vaginal cleansing even with tap water.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
10% povidone iodine
50 women who received preoperative vaginal cleansing with 10% povidone iodine.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2\. Pregnant women who are 37 weeks gestation or more with rupture of membranes but duration less than 24 hours
3\. Women consenting to be included in the study.
Exclusion Criteria
2. Intra-partum fever.
3. Prolonged rupture of membranes more than 24 hours
4. History of exposure to radiation treatment for cancer.
5. History of Gynecological infections (PID).
6. History of abdominal infections, e.g., peritonitis.
7. Debilitating diseases like Diabetes mellitus, Thyroid disorders, Cushing disease, abdominal malignancy.
8. Obesity is defined as pregnant BMI \>30 kg/m2.
9. History of wound infection or burst abdomen.
10. History suggestive of massive bleeding during previous cesarean section.
11. allergy to iodine-containing solutions
12. Pregnant women with severe anemia defined as Hb \<7 g/dl.
13. Cases with intra-abdominal drain deployment are discarded.
14. Obstructed labor with numerous vaginal examinations.
18 Years
38 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ahmed nagy shaker ramadan
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mostafa A Sleem, MD
Role: PRINCIPAL_INVESTIGATOR
Ethical and scientific committee
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
faculty of medicine - Cairo university
Cairo, Kasr El Ainy, Egypt
faculty of medicine, Kasr el ainy hospital, Cairo university
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Mohammad A Taymour, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
82019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.